Lantern Pharma
Stock Forecast, Prediction & Price Target

Lantern Pharma Financial Estimates

Lantern Pharma Revenue Estimates

Lantern Pharma EBITDA Estimates

Lantern Pharma Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $1.95M
Low: $1.95M
High: $1.95M
avg. 0%
Avg: $14.6M
Low: $14.6M
High: $14.6M
avg. 648.71%
Avg: $33.8M
Low: $33.8M
High: $33.8M
avg. 131.50%
Net Income
 
% change YoY
$-12.29M
 
N/A
$-14.08M
 
-14.57%
$-15.96M
 
-13.30%
Avg: $-27.65M
Low: $-21.90M
High: $-19.73M
avg. -73.27%
Avg: $-18.58M
Low: $-12.36M
High: $-12.36M
avg. 32.79%
Avg: $-13.87M
Low: $-13.87M
High: $-13.87M
avg. 25.33%
Avg: $-9.10M
Low: $-9.10M
High: $-9.10M
avg. 34.37%
EBITDA
 
% change YoY
$-12.58M
 
N/A
$-14.42M
 
-14.60%
$-15.78M
 
-9.45%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.13
 
N/A
-$1.3
 
-15.04%
-$1.47
 
-13.07%
Avg: -$1.92
Low: -$2.02
High: -$1.82
avg. -30.61%
Avg: -$1.14
Low: -$1.14
High: -$1.14
avg. 40.62%
Avg: -$1.28
Low: -$1.28
High: -$1.28
avg. -12.28%
Avg: -$0.84
Low: -$0.84
High: -$0.84
avg. 34.37%
Operating Expenses
 
% change YoY
$12.59M
 
N/A
$14.43M
 
14.62%
$17.87M
 
23.86%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Lantern Pharma stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 4.80% in 2025-2028.

We have gathered data from 1 analysts. Their low estimate is -21.90M, average is -27.65M and high is -19.73M.

What is Lantern Pharma stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 195.05% in 2025-2028.

We have gathered data from 2 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Lantern Pharma stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 8.02% in 2025-2028.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.02, average is -$1.92 and high is $-1.82.